Related Experiment Video

Updated: Jun 19, 2026

Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice

Published on: April 15, 2014

Early myoclonic encephalopathy

Mahesh Kamate1, Niranjana Mahantshetti, Vivek Chetal

  • 1Department of Pediatrics, Child Development Clinic, KLE University's J N Medical College, Belgaum, Karnataka State, India. drmaheshkamate@gmail.com

Indian Pediatrics
|October 9, 2009
PubMed

Insights

Early myoclonic encephalopathy (EME), a severe epilepsy syndrome, can be caused by non-ketotic hyperglycinemia. This case highlights a rare cause of EME in an infant, emphasizing the need for metabolic screening.

Area of Science:

  • Neurology
  • Metabolic Disorders
  • Epilepsy

Background:

  • Early myoclonic encephalopathy (EME) is a rare, severe epileptic encephalopathy presenting in early infancy.
  • Diagnostic criteria include myoclonus, onset before 3 months, and a characteristic EEG suppression-burst pattern.
  • The underlying etiology of EME is often unclear, necessitating comprehensive investigation.

Observation:

  • A case report of an 11-month-old infant presenting with symptoms consistent with EME is described.
  • The infant exhibited erratic myoclonus and focal motor seizures.
  • Electroencephalography (EEG) revealed a persistent suppression-burst pattern.

Findings:

  • The infant's EME was found to be secondary to non-ketotic hyperglycinemia, a rare metabolic disorder.
  • This finding identifies a specific metabolic cause for the severe epileptic syndrome in this patient.
  • Non-ketotic hyperglycinemia is a treatable condition, offering potential therapeutic avenues.

Implications:

  • This case underscores the importance of considering metabolic disorders, such as non-ketotic hyperglycinemia, in the differential diagnosis of EME.
  • Early identification and management of non-ketotic hyperglycinemia can potentially alter the clinical course of EME.
  • Further research into the metabolic underpinnings of EME is warranted to improve diagnostic and therapeutic strategies.

More Related Videos

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus05:33

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

Published on: June 23, 2022

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.